La Trobe

Protocol for implementation of the 'AusPROM' recommendations for elective surgery patients: a mixed-methods cohort study

Download (1.57 MB)
Version 3 2024-07-12, 02:02
Version 2 2024-07-11, 05:57
Version 1 2021-09-28, 04:31
journal contribution
posted on 2024-07-12, 02:02 authored by Meg MorrisMeg Morris, Natasha BruscoNatasha Brusco, Jeffrey Woods, PS Myles, Anita HodgeAnita Hodge, C Jones, Damien Lloyd, V Rovtar, A Clifford, V Atkinson
Introduction Incorporating patient-reported outcome measures (PROMs) into usual care in hospitals can improve safety and quality. Gaps exist in electronic PROM (ePROM) implementation recommendations, including for elective surgery. The aims are to: (1) understand barriers and enablers to ePROM implementation in hospitals and develop Australian ePROM implementation recommendations (AusPROM); (2) test the feasibility and acceptability of the Quality of Recovery 15 item short-form (QoR-15) PROM for elective surgery patients applying the AusPROM and (3) establish if the QoR-15 PROM has concurrent validity with the EQ-5D-5L. Methods and analysis Phase I will identify staff barriers and facilitators for the implementation of the AusPROM recommendations using a Delphi technique. Phase II will determine QoR-15 acceptability for elective surgery patients across four pilot hospitals, using the AusPROM recommendations. For phase II, in addition to a consumer focus group, patients will complete brief acceptability surveys, incorporating the QoR-15, in the week prior to surgery, in the week following surgery and 4 weeks postsurgery. The primary endpoint will be 4 weeks postsurgery. Phase III will be the national implementation of the AusPROM (29 hospitals) and the concurrent validity of the QoR-15 and generic EQ-5D-5L. This protocol adopts the Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trials Protocols guidelines. Ethics and dissemination The results will be disseminated via public forums, conferences and peer-reviewed journals. Ethics approval: La Trobe University (HEC20479). Trial registration number ACTRN12621000298819 (Phase I and II) and ACTRN12621000969864 (Phase III)

History

Publication Date

2021-09-16

Journal

BMJ Open

Volume

11

Issue

9

Article Number

e049937

Pagination

7p.

Publisher

BMJ

ISSN

2044-6055

Rights Statement

The Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.

Usage metrics

    Journal Articles

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC